Literature DB >> 11948470

Histologic classification of thymic epithelial tumors: comparison of established classification schemes.

Ralf J Rieker1, Josef Hoegel, Alicia Morresi-Hauf, Walter J Hofmann, Hendrik Blaeker, Roland Penzel, Herwart F Otto.   

Abstract

The object of our multicenter retrospective study was to compare the new histologic World Health Organization (WHO) classification and the classical histologic Bernatz classification in terms of interobserver agreement and prognostic importance. The influence of coexisting diseases was also analyzed using the Charlson score. We evaluated 218 patients from 5 different hospitals who were treated between 1967 and 1998. The statistical methods of analysis included Kaplan-Meier estimates of survival curves and the application of Cox proportional hazards models to identify sets of prognostic factors for survival. Interobserver agreement was assessed by kappa coefficients. For both WHO and Bernatz classifications, interobserver agreement was good (weighted kappa > 0.87). However, the subdiversification of the "bioactive" WHO subgroup (B1, B2, B3) resulted in an interobserver agreement of only 0.49 within this group. In multivariable models, both the WHO classification and the Bernatz classification including carcinomas showed similar prognostic capabilities. The B3 type in the WHO classification and the predominantly epithelial type in the Bernatz classification had an intermediate prognostic ranking in comparison with the carcinomas and with the other subgroups. For both classifications, further simplification and subclassification into 3 subgroups led to classes with good discriminative power in respect to survival. In addition, very good interobserver agreement was observed in the simplified classifications. Comorbidity, sex, age of the patient and lymphofollicular hyperplasia had no major influence on overall survival. Both classifications showed similar prognostic power. Interobserver agreement of the type B subgroups was only moderate. By simplification of the classifications, subgroups with distinct survival could be identified. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11948470     DOI: 10.1002/ijc.10255

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  31 in total

1.  The World Health Organization (WHO) histologic classification of thymomas: a reanalysis.

Authors:  Cesar A Moran; Saul Suster
Journal:  Curr Treat Options Oncol       Date:  2009-02-04

2.  Tumor epithelial tumors: do we expect a brighter or a grey future?

Authors:  Rolando M D'Angelillo; Sara Ramella
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

3.  Reproducibility of the WHO classification of thymomas: practical implications.

Authors:  P A Zucali; L Di Tommaso; I Petrini; S Battista; H S Lee; M Merino; E Lorenzi; E Voulaz; F De Vincenzo; M Simonelli; M Roncalli; L Giordano; M Alloisio; A Santoro; G Giaccone
Journal:  Lung Cancer       Date:  2012-12-29       Impact factor: 5.705

4.  Diffusion-weighted magnetic resonance imaging of thymoma: ability of the Apparent Diffusion Coefficient in predicting the World Health Organization (WHO) classification and the Masaoka-Koga staging system and its prognostic significance on disease-free survival.

Authors:  Adriano Massimiliano Priola; Sandro Massimo Priola; Maria Teresa Giraudo; Dario Gned; Alessandro Fornari; Bruno Ferrero; Lorena Ducco; Andrea Veltri
Journal:  Eur Radiol       Date:  2015-10-01       Impact factor: 5.315

5.  Thymic epithelial tumors: a clinicopathologic study of 249 cases from a single institution.

Authors:  Xue-Ying Su; Wei-Lu Wu; Nian Liu; Shang-Fu Zhang; Gan-Di Li
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

6.  Diagnostic reproducibility of thymic epithelial tumors using the World Health Organization classification: note for thoracic clinicians.

Authors:  Noriaki Sakakura; Hisashi Tateyama; Shigeo Nakamura; Tetsuo Taniguchi; Noriyasu Usami; Yoshinori Ishikawa; Koji Kawaguchi; Kohei Yokoi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-12-12

7.  FDG PET-CT aids in the preoperative assessment of patients with newly diagnosed thymic epithelial malignancies.

Authors:  Marcelo F K Benveniste; Cesar A Moran; Osama Mawlawi; Patricia S Fox; Stephen G Swisher; Reginald F Munden; Edith M Marom
Journal:  J Thorac Oncol       Date:  2013-04       Impact factor: 15.609

Review 8.  The enlightenments from ITMIG Consensus on WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting.

Authors:  Jie Wu; Wentao Fang; Gang Chen
Journal:  J Thorac Dis       Date:  2016-04       Impact factor: 2.895

9.  Clinicopathological analysis of 241 thymic epithelial tumors-experience in the Shanghai Chest Hospital from 1997-2004.

Authors:  Lei Zhu; Jie Zhang; Alexander Marx; Christel Weiss; Wen-Tao Fang
Journal:  J Thorac Dis       Date:  2016-04       Impact factor: 2.895

10.  The role of a pseudocapsula in thymic epithelial tumors: outcome and correlation with established prognostic parameters. Results of a 20-year single centre retrospective analysis.

Authors:  Sebastian Dango; Bernward Passlick; Ulf Thiemann; Gian Kayser; Christian Stremmel
Journal:  J Cardiothorac Surg       Date:  2009-07-15       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.